ReportCholesterol embolism: Still an unrecognized entity with a high mortality rate
Section snippets
Data collection
We collected and reviewed all clinical, laboratory, and histologic data of all cases of histologically proven CE seen in our hospital from January 1993 through March 2003. All patients were diagnosed and followed up at the same institution. The medical records of all affected patients were reviewed using a standardized form to collect clinical information (baseline atherosclerotic risk factors, previous atherosclerotic disease, possible precipitating factors, possible clinical CE-related signs
Patient population
Twenty-six patients with histologically proven CE were identified. All patients were white men (100%). Ages ranged from 48 to 88 years (mean age, 63.7 years). Six patients had peripheral CE (23%) with lower extremity signs without renal or other visceral disease. Twenty patients (77%) had visceral disease with peripheral embolism (17 patients) or without (3 patients). Risk factors for atherosclerosis and the frequency of preexisting atherosclerotic disease are listed in Table I. All patients
Discussion
CE is an increasing cause of morbidity and mortality in the aging, atherosclerotic, white population.11 The characteristics of our patients with multiple risk factors and previous symptomatic atherosclerosis were similar to those reported in previous series.8, 9, 12 Vascular radiologic procedures were the most common precipitating factor in our series, whereas spontaneous CE was uncommon. In early reports, a greater percentage of patients with CE showed a spontaneous form of the disease8, 16;
Conclusion
CE is a not uncommon complication of atherosclerosis that often remains unrecognized because of its nonspecific clinical findings. CE should be strongly considered in elderly patients with atherosclerotic vascular disease and history of a precipitating factor, who develop renal insufficiency and often a sudden onset of livedo reticularis or cyanotic toes. In patients with chronic renal failure, prudence dictates careful evaluation before embarking upon invasive procedures or other precipitating
References (23)
- et al.
Redefining the incidence of clinically detectable atheroembolism
Am J Med
(1996) - et al.
The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study
J Am Coll Cardiol
(2003) - et al.
Supportive treatment improves survival in multivisceral cholesterol crystal embolism
Am J Kidney Dis
(1999) - et al.
Cholesterol crystal embolism: a recognizable cause of renal disease
Am J Kidney Dis
(2000) - et al.
Cholesterol crystal embolization to the digestive system: characterization of a common, yet overlooked presentation of atheroembolism
Am J Gastroenterol
(2003) - et al.
Lower extremity atheromatous embolization
Am J Surg
(1976) - et al.
The cutaneous manifestations of cholesterol crystal embolization
Arch Dermatol
(1986) - et al.
Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations
J Eur Acad Dermatol Venereol
(2003) - et al.
Livedo reticularis: an underutilized diagnostic clue in cholesterol embolization syndrome
Am J Med Sci
(2001) - et al.
Enfermedad por embolos de colesterol: estudio de 16 casos
Rev Clin Esp
(2000)
Atheroembolic renal failure requiring dialysis: potential for renal recovery?
Nephron Clin Pract
Cited by (0)
Funding sources: None.
Conflicts of interest: None identified.